Pharmaceutical - Publications - Faculty & Research

01 Jan 2002
News

Raymond V. Gilmartin (MBA '68)

the business world has an important leadership role to play in terms of closing the gap in health and other vital social issues," he says. When Ray Gilmartin joined Merck in June 1994 as president and CEO (he became chairman several months later), it was the first time... View Details

Profile

Thomas Grenier

passion and by the many opportunities to indulge my own passions and interests, such as exploring the pharmaceuticals and healthcare fields through specialized coursework and a field study with a very promising medical imaging start-up.... View Details

24 Aug 2020
Blog Post

My Journey to Joining the first MS/MBA Biotechnology: Life Sciences Cohort

forecasting expected revenues, to developing an equity investing plan for a major pharmaceutical company and performing due diligence on M&A targets. I also spent four months on secondment within a pharma company's Commercial Oncology... View Details

01 Sep 2010
News

Reinventing the Annual Report

in this effort, including Southwest Airlines (with its Southwest Airlines One Report), United Technologies Corporation (UTC), the Dutch electronics and health-care giant Philips, the German chemical company BASF, and Danish pharmaceutical... View Details

Keywords: Robert G. Eccles

01 Sep 2011
News

MBA 101: HBS Commencements Pass the Century Mark

pharmaceutical executive at the time of her diagnosis with multiple myeloma, an incurable, rare, and little-researched blood cancer, Giusti went on to found the Multiple Myeloma Research Foundation and the Multiple Myeloma Research... View Details

Keywords: commencement; Colleges, Universities, and Professional Schools; Educational Services

01 May 2007
First Look

First Look: May 1, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207113 Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc. Harvard Business School Case 707-509 The global View Details

Keywords: Sean Silverthorne

13 Jul 2020
News

Locally Grown

pharmaceutical machinery sector. With the natural beauty of the Rocky Mountains as a backdrop for his career decision, Fenwick-Smith became increasingly interested in climate change and what the business community could do to make a... View Details

Keywords: April White

01 Oct 2013
First Look

First Look: October 1

these issues, increase performance, and set a direction for the company, all while remaining true to the values of his family's business. Purchase this case: http://hbr.org/search/413086-PDF-ENG Harvard Business School Case 313-016 Shanghai View Details

Keywords: Sean Silverthorne

17 Mar 2009
First Look

First Look: March 17, 2009

Agreements in Bio-Pharmaceuticals Authors:Juan Alcácer, John Cantwell, and Michelle Gittelman Publication:In Location of Biopharmaceutical Activity, edited by Iain M. Cockburn and Matthew J. Slaughter. NBER, forthcoming. Abstract As the value chain of the View Details

Keywords: Martha Lagace

Web

Kraft Accelerator

Investing Harvard Business Publishing Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Business Publishing Learn how, and why, we got our start HEAR OUR MISSION Before you... View Details

08 Aug 2017
First Look

First Look at Research and Ideas, August 8, 2017

School Case 415-013 Novartis Pharmaceuticals Corp: Redefining Success in the U.S. (A) Over the course of a tumultuous weekend in April 2010, André Wyss was put in charge of Novartis Pharmaceuticals... View Details

Keywords: Sean Silverthorne

Profile

Evan Rachlin

experienced as a medical student, business issues are an inescapable reality for any physician. While shadowing a pediatrician in private practice, he noticed the tension between the busy physician and a pharmaceutical representative... View Details

01 Dec 2003
News

Alumni Luminaries Discuss Careers, Values with HBS Students

Internal Revenue Service. Senior advisor, The Carlyle Group. He upgraded technology and information systems and stressed customer service in a dramatic turnaround of the IRS. Daniel L. Vasella, M.D. (PMD 57, 1989), chairman and CEO of Novartis AG, the world’s... View Details

01 Mar 2009
News

A New Approach to Health-Care Reform

approach not just to insurance and reimbursement, but also to the places where medical services are delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs... View Details

Keywords: Deborah Blagg; Health, Social Assistance

Student-Profile

Olivia Zhao

pros and cons of a public system facing increased privatization. Research Olivia’s research hones in on the pharmaceutical industry and looking at the lifecycle of a drug. “It starts, of course, with research and development at huge drug... View Details

01 Jan 2004
News

Donald P. Nielsen, MBA 1963

self-cleaning rat cages for psychology labs. Learning that pharmaceutical companies use large quantities of rats, they negotiated a deal with him and over the next few months also executed a roll-up strategy that eventually made them the... View Details

Profile

Thomas Grenier

biotech investments. "I showed that it was far more profitable in the United States and that U.S. companies are better at developing new drugs." Thomas will continue to explore health care in his summer internship with Sanofi-Aventis, where he will work on... View Details

Profile

Carter Romansky

The creative side of the pharmaceutical industry engaged Carter Romansky in every aspect of the business: science, marketing, finance, law. But when his job became "less about its original goal (creating value for patients through... View Details

01 Dec 2003
Research & Ideas

Sometimes Success Begins at Failure

In the late 1980s, scientists for New York City-based drug-maker Pfizer began testing what was then known as compound UK-92,480 for the treatment of angina. Although UK-92,480 seemed promising in the lab and in animal tests, the compound showed little benefit in... View Details

Keywords: by Henry Chesbrough; Pharmaceutical; Pharmaceutical